共 26 条
[1]
Anderson, Peck, Clark, Estrogen-induced uterine responses and growth: Relationship to receptors-estrogen binding by uterine nuclei, Endocrinology, 96, (1975)
[2]
Andreyko, Blumenfeld, Marshall, Monroe, Hricak, Jaffe, Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging, Am J Obstet Gynecol, 158, (1988)
[3]
Baird, West, Medical management of fibroids, Br Med J, 296, (1988)
[4]
Baird, Bramley, Hawkins, Lumsden, West, Effect of treatment with LHRH analogue zoladex on binding of oestradiol, progesterone and epidermal growth factor to uterine fibromyomata, Hormone Res, 32, (1989)
[5]
Buttram, Reiter, Uterine leiomyomata: etiology, symptomatology, and management., Fertil Steril, 36, (1981)
[6]
Corbin, Beattie, Tracy, Jones, Foell, Yardley, Rees, The anti-reproductive pharmacology of LHRH and agonist analogues, Int J Fertil, 23, (1978)
[7]
Crona, Enk, Samsioe, Silfverstalpe, Skryten, High-dose depot-medroxyprogesterone acetate (DMPA) — effects on lipid and lipoprotein metabolism, European Journal of Obstetrics & Gynecology and Reproductive Biology, 16, (1983)
[8]
Fahraeus, Sydsjo, Wallentin, Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate., Fertil Steril, 45, (1986)
[9]
Filicori, Hall, Loughlin, Rivier, Vale, Crowley, A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue, Am J Obstet Gynecol, 147, (1983)
[10]
Friedman, Barbieri, Doubilet, A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprosterone acetate in the treatment of leiomyomata uteri, Fertil Steril, 49, (1988)